STAT protein family and cardiovascular diseases: overview of pathological mechanisms and therapeutic implications

被引:0
|
作者
Ghader Babaei
Samin Sadraei
Maral Yarahmadi
Samareh Omidvari
Aryan Aarabi
Masoumeh Rajabibazl
机构
[1] Urmia University of Medical Sciences,Department of Clinical Biochemistry, Faculty of Medicine
[2] Shahid Beheshti University of Medical Sciences,Faculty of Medicine
[3] Shahid Beheshti University of Medical Sciences,Department of Clinical Biochemistry, Faculty of Medicine
来源
Molecular Biology Reports | 2024年 / 51卷
关键词
Cardiovascular diseases; Pathological mechanisms; STAT family proteins;
D O I
暂无
中图分类号
学科分类号
摘要
Globally, cardiovascular diseases (CVD) are one of the significant causes of death and are considered a major concern of human society. One of the most crucial objectives of scientists is to reveal the mechanisms associated with the pathogenesis of CVD, which has attracted the attention of many scientists. Accumulating evidence showed that the signal transducer and activator of transcription (STAT) signaling pathway is involved in various physiological and pathological processes. According to research on the molecular mechanisms of CVDs, the STAT family of proteins is one of the most crucial players in these diseases. Numerous studies have demonstrated the undeniable relevance of STAT family proteins in various CVDs. The aim of this review is to shed light on how STAT signaling pathways are related to CVD and the potential for using these signaling pathways as therapeutic targets.
引用
收藏
相关论文
共 50 条
  • [1] STAT protein family and cardiovascular diseases: overview of pathological mechanisms and therapeutic implications
    Babaei, Ghader
    Sadraei, Samin
    Yarahmadi, Maral
    Omidvari, Samareh
    Aarabi, Aryan
    Rajabibazl, Masoumeh
    [J]. MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [2] Role of Specificity Protein 1 (SP1) in Cardiovascular Diseases: Pathological Mechanisms and Therapeutic Potentials
    Ding, Jie
    Fayyaz, Aminah I.
    Ding, Yuchuan
    Liang, Dandan
    Luo, Ming
    [J]. BIOMOLECULES, 2024, 14 (07)
  • [3] Pathological implications of cellular stress in cardiovascular diseases
    Ulaganathan, Thennavan
    Perales, Selene
    Mani, Saiprahalad
    Baskhairoun, Boula A.
    Rajasingh, Johnson
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023, 158
  • [4] The pivotal role of neutrophil extracellular traps in cardiovascular diseases: Mechanisms and therapeutic implications
    Geng, Xinyu
    Wang, Dao Wen
    Li, Huihui
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [5] Therapeutic Implications of PPARγ in Cardiovascular Diseases
    Hasegawa, Hiroshi
    Takano, Hiroyuki
    Komuro, Issei
    [J]. PPAR RESEARCH, 2010, 2010
  • [6] Lysosomal storage diseases: pathological mechanisms and therapeutic options
    Futerman, AH
    [J]. M S-MEDECINE SCIENCES, 2005, 21 : 16 - 19
  • [7] Cell death regulation by MAMs: from molecular mechanisms to therapeutic implications in cardiovascular diseases
    Li, Yiran E.
    Sowers, James R.
    Hetz, Claudio
    Ren, Jun
    [J]. CELL DEATH & DISEASE, 2022, 13 (05)
  • [8] Cell death regulation by MAMs: from molecular mechanisms to therapeutic implications in cardiovascular diseases
    Yiran E. Li
    James R. Sowers
    Claudio Hetz
    Jun Ren
    [J]. Cell Death & Disease, 13
  • [9] Therapeutic Potential of Chymase Inhibitors in Cardiovascular Diseases: An Overview
    Aga, Qutaiba Ahmed Al Khames
    Nair, Anroop B.
    Hourani, Wafa
    Parasuraman, Subramani
    Ahmed, Mueen K. K.
    Sreeharsha, Nagaraja
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2020, 54 (03) : 509 - 516
  • [10] Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
    Zhong, Qian
    Xiao, Xina
    Qiu, Yijie
    Xu, Zhiqiang
    Chen, Chunyu
    Chong, Baochen
    Zhao, Xinjun
    Hai, Shan
    Li, Shuangqing
    An, Zhenmei
    Dai, Lunzhi
    [J]. MEDCOMM, 2023, 4 (03):